Deutsche Bank analyst George Hill noted that Tuesday after the market closed, Bloomberg reported that 87% of CVS Aetna Medicare members are enrolled in 4+ Star plans in 2024, linking to a CVS press release the company appears to have pulled. CMS has not yet released the Stars performance data, though the firm would view the news as being “a clear positive if true,” the analyst tells investors. However, to “some degree” the news would be as expected as CVS has telegraphed this in recent meetings. Deutsche maintains a Hold rating on CVS shares with a price target of $81.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CVS:
- Agilon Health price target lowered to $20 from $21 at Evercore ISI
- CVS Health price target lowered to $80 from $93 at Bernstein
- Walgreens (NYSE:WBA) Staff Could Stage a Walkout Today
- COWZ, SYLD: Two Unique ETFs with Scorching Returns
- Novavax Stock (NASDAQ:NVAX) Surged After Winning the FDA’s Approval
